Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy

Neoadjuvant chemotherapy (NAC) is a significant modality in breast cancer therapy. We sought to characterize prognostic factors in patients scheduled for NAC who had a pretreatment positron-emission tomography paired with diagnostic quality contrast-enhanced computed tomography (CT) (positron-emissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrugia, Mark K., Wen, Sinjen, Jacobson, Geraldine M., Salkeni, Mohamad Adham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216743/
https://www.ncbi.nlm.nih.gov/pubmed/30505226
http://dx.doi.org/10.4103/wjnm.WJNM_84_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216743/
https://www.ncbi.nlm.nih.gov/pubmed/30505226
http://dx.doi.org/10.4103/wjnm.WJNM_84_17

Ejemplares similares